, of Part I of this report contains statistical data and estimates, including forecasts, that are based on information provided by Gartner, Inc. ("Gartner") in "Forecast: Semiconductor Capital Spending, Wafer Fab Equipment and Capacity, Worldwide, 4Q25 Update, Bob Johnson et al., December 23, 2025." GARTNER is a trademark of Gartner, Inc. and its affiliates. The Gartner Content described herein…
$83.92
$0.17 (-0.20%)
EOD Jul 17, 2026
12.14% operating margin is respectable but not wide. ROIC at 6.73%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 15.2%, still solid. Margins contracted 7.2pp, which offsets some of the top-line progress.
At 64x earnings, the current multiple leaves limited room for execution misses or growth deceleration. Free cash flow declined 195% versus the prior year, cash generation momentum has weakened.
64.1x earnings. The market is pricing in years of above-average growth. If that thesis breaks, downside from multiple compression alone could be 30%+. This is a stock where you're paying for the future, not the present.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$960M
▲ +15.2% YoY
Net Income (TTM)
$91M
▼ -9.2% YoY
Op. Margin
12.48%
▼ -7.2pp YoY
ROIC
6.28%
▼ -5.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$107M
▼ -195.2% YoY
Op. Cash Flow (TTM)
-$45M
▼ -106.8% YoY
Net Debt
-$570M
Net Cash Position
Cash & Equiv.
$907M
5Y CAGR: +41.9%
Continue Research
At a P/E of 64.1, Acm Research (ACMR)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Acm Research scores 29/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Acm Research scores 29 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a 12.5% operating margin and a 6.3% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh ACMR's valuation and scores 29/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.